Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.8575
+0.02753.31%
Post-market: 0.91200.0545+6.36%17:38 EDT
Volume:113.48K
Turnover:98.73K
Market Cap:22.86M
PE:-3.00
High:0.9000
Open:0.8441
Low:0.8310
Close:0.8300
52wk High:3.40
52wk Low:0.7069
Shares:26.65M
Float Shares:21.83M
Volume Ratio:1.20
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.22
PE(LYR):-2.18

Loading ...

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD

GlobeNewswire
·
Yesterday

Lilly’s Brenipatide Steps Into Phase 3: A New Long-Term Play in Depression Care

TIPRANKS
·
Aug 28

ABVC BioPharma Completes BioKey Cayman Spin-Off Transaction

TIPRANKS
·
Aug 27

ABVC Biopharma Completes BioKey Cayman Spinoff, Distributes 15% Stake to Shareholders

Reuters
·
Aug 27

Press Release: Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Dow Jones
·
Aug 13

ABVC Biopharma FY26 Q2 Net Loss Narrows 65% to $810,481

Reuters
·
Aug 13

ABVC BioPharma Delays BioKey (Cayman) Share Distribution to Aug. 21 from Aug. 3 in 8-K Amendment

Reuters
·
Aug 13

ABVC Biopharma - Biokey (Cayman) Share Distribution Rescheduled for August 21, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 13

ABVC Biopharma - Postpones Biokey (Cayman) Share Distribution - SEC Filing

THOMSON REUTERS
·
Aug 13

Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile

GlobeNewswire
·
Aug 11

Collegium Q2 2026 earnings: ADHD growth offsets pain portfolio pressure

TradingKey
·
Aug 07

Yukiguni Maitake Sees FY Net Y2.54b

Dow Jones
·
Aug 06

BlinkLab's ADHD European Case-Control Study Achieves High Sensitivity, Specificity Results; Shares Jump 10%

MT Newswires Live
·
Aug 05

NASDAQ Trade Halt Halt News Pending at 04:43 Pm

Reuters
·
Aug 04

Press Release: Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Dow Jones
·
Aug 03

BlinkLab requests ASX trading halt ahead of material ADHD study results

TIPRANKS
·
Aug 03

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 01

Buy Rating Reaffirmed on Contineum Therapeutics with Unchanged $26 Price Target, Backed by Advancing IPF and MDD Pipelines

TIPRANKS
·
Aug 01

ABVC Biopharma Announces Special Shareholder Meeting

Reuters
·
Jul 29

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

GlobeNewswire
·
Jul 28